Literature DB >> 9007590

Procalcitonin in patients with and without immunosuppression and sepsis.

B al-Nawas1, P M Shah.   

Abstract

High serum levels of procalcitonin (PCT) are observed in patients with sepsis or severe infection. In a prospective study of 122 hospitalised adult medical patients with sepsis, serum PCT was determined on admission and for 9 days thereafter. Patients with no alteration in their immune system showed high PCT values up to day 5, decreasing to normal levels by day 9. Patients with sepsis and immunodeficiency had high values on days 0 to 2, similar to the first group, but showed significantly lower levels on the following 3 days. PCT concentrations fell to base line levels on days 6 to 9 of the sepsis episode in both groups. The observed difference was not significantly related to the kind of causative microorganism or a culture negative sepsis. Leukopenia seemed to go together with lower PCT values after day 2 of the episode, but this could not be proven statistically.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9007590     DOI: 10.1007/bf01713044

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

Review 1.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

2.  A novel calcitonin-encoding mRNA is produced by alternative processing of calcitonin/calcitonin gene-related peptide-I pre-mRNA.

Authors:  G J Adema; P D Baas
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

3.  Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.

Authors:  P P Ghillani; P Motté; F Troalen; A Jullienne; P Gardet; T Le Chevalier; P Rougier; M Schlumberger; C Bohuon; D Bellet
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

4.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

5.  Procalcitonin in diagnosis of severe infections.

Authors:  B Al-Nawas; I Krammer; P M Shah
Journal:  Eur J Med Res       Date:  1996-04-18       Impact factor: 2.175

6.  PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinoma.

Authors:  F Raue; E Blind; A Grauer
Journal:  Henry Ford Hosp Med J       Date:  1992

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies.

Authors:  E Rintala; K Pulkki; J Mertsola; T Nevalainen; J Nikoskelainen
Journal:  Scand J Infect Dis       Date:  1995
  8 in total
  17 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study.

Authors:  Ansgar Michael Chromik; Frank Endter; Waldemar Uhl; Arnulf Thiede; Hans Bernd Reith; Ulrich Mittelkötter
Journal:  Langenbecks Arch Surg       Date:  2005-12-21       Impact factor: 3.445

3.  Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis.

Authors:  C Cosse; C Sabbagh; F Browet; F Mauvais; L Rebibo; E Zogheib; D Chatelain; S Kamel; J M Regimbeau
Journal:  Surg Endosc       Date:  2015-02-21       Impact factor: 4.584

4.  Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation.

Authors:  N M Blijlevens; J P Donnelly; J F Meis; M H De Keizer; B E De Pauw
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

5.  Usefulness of procalcitonin for diagnosis of infective endocarditis.

Authors:  Matjaz Jereb; Tadeja Kotar; Tomaz Jurca; Tatjana Lejko Zupanc
Journal:  Intern Emerg Med       Date:  2009-04-09       Impact factor: 3.397

6.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

7.  Procalcitonin-a new diagnostic tool in complications following liver transplantation.

Authors:  E R Kuse; I Langefeld; K Jaeger; W R Külpmann
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

8.  Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Authors:  Nicolas Penel; Charles Fournier; Stéphanie Clisant; Michèle N'Guyen
Journal:  Support Care Cancer       Date:  2004-02-10       Impact factor: 3.603

9.  PCT as a Prognostic Marker in Cardiac Patients with Neutropenic Sepsis: Two Case Reports.

Authors:  Neelima Verma; Shaloo Kapoor; Deepa Rao; Siddhartha Sharma; Anita Arora
Journal:  Indian J Clin Biochem       Date:  2013-10-02

10.  Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics.

Authors:  João Manoel Silva; Sigrid De Sousa dos Santos
Journal:  J Int AIDS Soc       Date:  2013-01-30       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.